Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy.
about
Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.Parallel Expression of Enzyme Inhibitors of CD8T Cell Activity in Tumor Microenvironments and Secretory Endometrium.Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug.Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI-PEG20 treatment in CCA cell lines.
P2860
Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Argininosuccinate synthetase ( ...... personalized targeted therapy.
@ast
Argininosuccinate synthetase ( ...... personalized targeted therapy.
@en
type
label
Argininosuccinate synthetase ( ...... personalized targeted therapy.
@ast
Argininosuccinate synthetase ( ...... personalized targeted therapy.
@en
prefLabel
Argininosuccinate synthetase ( ...... personalized targeted therapy.
@ast
Argininosuccinate synthetase ( ...... personalized targeted therapy.
@en
P2093
P2860
P1476
Argininosuccinate synthetase ( ...... personalized targeted therapy.
@en
P2093
Ann E Walts
Delma Ines
John S Bomalaski
Sandra Orsulic
P2860
P2888
P304
P356
10.1007/S00432-014-1904-Z
P577
2014-12-30T00:00:00Z